Marketing - Press Releases

Date	Title	Company
15-Jul-2020	Macomics, an immuno-oncology company, secures £3.2 million seed funding from Epidarex Capital & the Scottish Investment Bank	Macomics Ltd
15-Jul-2020	CARDIOVASCULAR MEDTECH SECTOR TO ENJOY STRONG GROWTH BUT IT NEEDS A BIGGER FOCUS ON DATA AND REAL-WORLD EVIDENCE	Zegami
15-Jul-2020	Transgene and Hypertrust Patient Data Care announce successful go-live of the world’s first blockchain solution for clinical trials of personalized healthcare	Transgene and Hypertrust Patient
15-Jul-2020	Sermonix Pharmaceuticals to Collaborate With Eli Lilly and Company in Studying Combination of Lasofoxifene and Lilly’s CDK 4 and 6 Inhibitor, Abemaciclib, in Metastatic Breast Cancer	Sermonix Pharmaceuticals Inc
15-Jul-2020	INTELLEGENS AWARDED FUNDING BY INNOVATE UK TO MODEL COVID-19 DATA AND IMPROVE PANDEMIC MANAGEMENT	Intellegens
15-Jul-2020	Koura announces major investment into new ‘greener’ medical propellant production facility in United Kingdom	Koura
15-Jul-2020	Sosei Heptares notes Enerzair® Breezhaler® approval in the European Union as a treatment for uncontrolled asthma	Sosei Group Corporation
15-Jul-2020	Novartis receives EC approval for Enerzair® Breezhaler®, including the first digital companion (sensor and app) that can be prescribed alongside a treatment for uncontrolled asthma in the EU	Novartis
15-Jul-2020	Rates of bleeding and venous thromboembolism (VTE) events reported after 12 months of edoxaban ▼ treatment considered low by real-world ETNA-VTE study investigators	Daiichi Sankyo
15-Jul-2020	Acacia Pharma Assigned US License for BYFAVO™ (remimazolam) by Cosmo Pharmaceuticals NV	Acacia Pharma
15-Jul-2020	Bridge Biotherapeutics becomes BaseLaunch’s first Asia Pacific partner	BaseLaunch
15-Jul-2020	J&J's price reduction of lifesaving TB drug is an important step; governments must scale up use	Johnson & Johnson
08-Jul-2020	Lynparza approved in the EU for BRCA-mutated metastatic pancreatic cancer	AstraZeneca PLC
06-Jul-2020	Greensill provides much needed cash to England’s Pharmacies	Greensill
03-Jul-2020	Hansa Biopharma announces exclusive agreement with Sarepta Therapeutics to develop and promote imlifidase as pre-treatment ahead of gene therapy in select indications	Hansa Biopharma
03-Jul-2020	Biophytis announces a € 6.1 million capital increase through private placement	Biophytis SA
03-Jul-2020	Acacia Pharma Announces US FDA Approval of BYFAVO™ (remimazolam) for injection for the Induction and Maintenance of Procedural Sedation	Acacia Pharma
03-Jul-2020	Sanofi and Regeneron provide update on Kevzara® (sarilumab) Phase 3 U.S. trial in COVID-19 patients	Sanofi
03-Jul-2020	Consilium Strategic Communications Advises Hyloris Pharmaceuticals on its Successful Initial Public Offering	Consilium Strategic Communications
02-Jul-2020	(Covid-19) Impact Analysis : Ciprofloxacin Hcl Market Size, Trends, Analysis, Demand, Outlook and Forecast to 2026	Qurate Business Intelligence